Published: 1 June 2023
Publications
Quarterly summary of recent safety communications
Published: 1 June 2023
Prescriber Update 44(2): 31
June 2023
The table below is a summary of recent safety communications for
health care professionals and consumers. Click on a specific topic to
go to the communication.
| Date |
Communication |
Topic |
| 09/05/2023 |
Monitoring |
Interleukin inhibitors and the possible risk of pancreatitis
|
| 27/04/2023 |
Information leaflet |
Risks of opioid medicines (Te Reo version) (PDF, 2 pages,
235 KB) |
| 26/04/2023 |
Information leaflet |
Stopping antidepressants: be cautious and go slow (PDF,
2 pages, 294 KB) |
| 26/04/2023 |
Monitoring |
Review of pholcodine-containing medicines – Provide your feedback
by 8 May 2023 |
| 12/04/2023 |
Alert |
Topiramate use in pregnancy: further restrictions for safety
|
| 06/04/2023 |
Dear Healthcare Professional Letter |
Topamax
(topiramate): Pregnancy-related safety update (PDF, 4 pages,
232 KB) |
| 27/03/2023 |
Monitoring |
Update – Abnormal uterine bleeding and oral anticoagulants (blood
thinners) |
| 20/03/2023 |
Alert |
New legislation about medicines that can impair driving
|
| 02/03/2023 |
Monitoring |
Reports
of pericarditis following mpox vaccination |
| 23/02/2023 |
Dear Healthcare Professional Letter |
Lagevrio (molnupiravir) 200 mg capsules - Extension to shelf
life of stock in market (PDF, 2 pages, 223 KB) |
| 22/02/2023 |
Information leaflet |
Nhan Sam Tuyet Lien Truy Phong Hoan capsules – information
for patients in:
English,
Samoan and
Tongan (PDF, 1 page, 570 KB each) |
| 06/02/2023 |
Dear Healthcare Professional Letter |
Dexmedetomidine: Increased risk of mortality in intensive care
unit (ICU) patients ≤63.7 years (PDF, 3 pages, 835 KB)
|
| 24/01/2023 |
Dear Healthcare Professional Letter |
Shelf life extension of Paxlovid (nirmatrelvir 150 mg/ritonavir
100 mg) film coated tablets (PDF, 3 pages, 193 KB) |
